Lentiviral gene transfer to the nonhuman primate brain

Experimental Neurology

Volumn 160, Issue 1, 1999, Pages 1-16

  Kordower, Jeffrey H ^a   Bloch, Jocelyne ^b   Ma, Shuang Y ^a   Chu, Yaping ^a   Palfi, Stéphane ^a   Roitberg, Ben Zion ^a,b   Emborg, Marina ^a   Hantraye, Philippe ^c   Déglon, Nicole ^d   Aebischer, Patrick ^d  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c DIF   (France)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAUDATE NUCLEUS; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; GENE TRANSFER; GENETIC TRANSDUCTION; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; INOCULATION; LENTIVIRINAE; MALE; MARKER GENE; NIGRONEOSTRIATAL SYSTEM; NISSL SUBSTANCE; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; PUTAMEN; RHESUS MONKEY; STEREOMETRY; VIRUS INFECTIVITY;

EID: 0032752994     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1999.7178     Document Type: Article

References (35)

1. Bankiewicz K. S., Bringas J. R., McLaughlin W., Pivirotto P., Hundal R., Yang B., Emborg M. E., Nagy D. Application of gene therapy for Parkinson's disease: Nonhuman primate experience. Adv. Pharmacol. 42:1998;801-806.
2. Bankiewicz K. S., Leff S. E., Nagy D., Jungles S., Rokovich J., Spratt K., Cohen L., Libonati M., Snyder R. O., Mandel R. J. Practical aspects of the development of ex vivo and in vivo gene therapy for Parkinson's disease. Exp. Neurol. 144:1997;147-156.
3. Bartus R. T., Dean R. L., Beer B., Lippa A. S. The cholinergic hypothesis of geriatric memory dysfunction. Science. 217:1982;408-417.
4. Blomer U., Naldini L., Kafri T., Trono D., Verma I. M., Gage F. H. Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J. Virol. 71:1997;6641-6649.
5. Blomer U., Kafri T., Randolph-Moore L., Verma I. M., Gage F. H. Bcl-xL protects adult septal cholinergic neurons from axotomized cell death. Proc. Natl. Acad. Sci. USA. 95:1998;2603-2608.
6. Bohn M. C., Choi-Lundberg D. L., Davidson B. L., Leranth C., Kozlowski D. A., Smith J. C., O'Banion M. K., Redmond D. E. Adenoviral-mediated gene expression in the nonhuman primate brain. Hum. Gene Ther. 1999.
7. Bray M., Prasad S., Dubay J. W., Hunter E., Jeang K.-T., Rekosh D., Hammarskjöld M.-L. A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent. Proc. Natl. Acad. Sci. USA. 91:1994;1256-1260.
8. Connor B., Dragunow M. The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res. Brain Res. Rev. 27:1998;1-39.
9. Davidson B. L., Doran S. E., Shewach D. S., Latta J. M., Hartman J. W., Roessler B. J. Expression of escherichia coli beta-galactosidase and rat HPRT in the CNS of Macaca mulatta following adenoviral mediated gene transfer. Exp. Neurol. 125:1994;258-267.
10. Déglon N. J., Tseng L., Bensadoun J.-C., Zufferey R., Trono D., Aebischer P. Protection of dopaminergic neurons from axotomy-induced degeneration with a GDNF-expressing lentiviral vector. Soc. Neurosci. Abstr. 24:1998;1008.
11. Donello J. E., Loeb J. E., Hope T. J. Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element. J. Virol. 72:1998;5085-5092.
12. Donello J. E., Beeche A. A., Smith G. J. III, Lucero G. R., Hope T. J. The hepatitis B virus posttranscriptional regulatory element is composed of two subelements. J. Virol. 70:1996;4345-4351.
13. Emborg M. E., Ma S. Y., Mufson E. J., Levey A. I., Taylor M. D., Brown W. D., Holden J. E., Kordower J. H. Age-related declines in nigral neuronal function correlate with motor impairments in Rhesus monkeys. J. Comp. Neurol. 401:1998;253-265.
14. Emerich D. F., Shelley R., Winn S. R., Hammang J. P., Baetge E. E., Kordower J. H. Grafts of polymer-encapsulated cells genetically modified to secrete nerve growth factor rescue basal forebrain neurons in nonhuman primates. J. Comp. Neurol. 349:1994;148-165.
15. Goodman J. C., Trask T. W., Chen S. H., Woo S. L., Grossman R. G., Carey K. D., Hubbard G. B., Carrier D. A., Rajagopalan S., Aguilar-Cordova E., Shine H. D. Adenoviral-mediated thymidine kinase gene transfer into the primate brain followed by systemic ganciclovir: Pathologic, radiologic, and molecular studies. Hum. Gene Ther. 7:1996;1241-1250.
16. Grondin R., Gash D. M. Glial cell line-derived neurotrophic factor (GDNF): A drug candidate for the treatment of Parkinson's disease. J. Neurol. 245:1998;35-42.
17. Gundersen H. J. G., Bagger P., Bendtsen T. F., Evans S. M., Korbo L., Marcussen M., Møller A., Nielsen K., Nyengaard J. R., Pakkenberg B., Sørensen F. B., Vesterby A., West M. J. The new stereological tools: Dissector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS. 96:1988;857-881.
18. Julias J. G., Hash D., Pathak V. K. E- vectors: development of novel self inactivating and self-activating retroviral vectors for safer gene therapy. J. Virol. 69:1995;6839-6846.
19. Kordower, J. H, S. Palfi, E.-Y. Chen, S. Y. Ma, T. Sendera, E. J. Cochran, E. J. Mufson, R. Penn, C. G. Goetz, and, C. D. Comella, Clinico-pathological findings following intraventricular GDNF treatment in a patient with Parkinson's disease, Ann. Neurol, in press.
20. Kordower J. H., Fiandaca M. S. Response of the monkey septohippocampal system to fornix transection: A histochemical and cytochemical analysis. J. Comp. Neurol. 298:1990;443-457.
21. Lapchak P. A., Gash D. M., Collins F., Hilt D., Miller P. J., Araujo D. M. Pharmacological activities of glial cell line-derived neurotrophic factor (GDNF): Preclinical development and application to the treatment of Parkinson's disease. Exp. Neurol. 145:1997;309-321.
22. Ma, S. Y. 1997, The substantia nigra in Parkinson's disease: A morphometric study on neuronal changes. Academical thesis, University of Turku, Finland 1-100.
23. Miyoshi H., Takahashi M., Gage F. H., Verma I. M. Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proc. Natl. Acad. Sci. USA. 94:1997;10319-10323.
24. Naldini L., Blömer U., Gage F. H., Trono D., Verma I. M. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. USA. 93:1996;11382-11388.
25. Naldini L., Blömer U., Gallay P., Ory D., Mulligan R., Gage F. H., Verma I. M., Trono D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science. 272:1996;263-267.
26. Palfi S. C., Comella C., Jaglin J., Penn R. D., Cochran E. J., Kladis T., Chen E.-Y., Kordower J. H. Clinico-pathological findings following intraventricular GDNF treatment in a patient with Parkinson's disease. Soc. Neurosci. Abstract. 24:1998.
27. Reiser J., Harmison G., Kluepfel-Stahl S., Brady R. O., Karlsson S., Schubert M. Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles. Proc. Natl. Acad. Sci. USA. 93:1996;15266-15271.
28. Tuszynski M. H., Sang H., Yoshida K., Gage F. H. Recombinant human nerve growth factor infusions prevent cholinergic neuronal degeneration in the adult primate brain. Ann. Neurol. 5:1991;625-636.
29. West M. J., Ostergaard K., Andreassen O. A., Finsen B. Estimation of the number of somatostatin neurons in the striatum: An in situ hybridization study using the optical fractionator method. J. Comp. Neurol. 370:1996;11-22.
30. Wim T. J., Hermens M. C., Verhaagen J. Viral vectors, tools for gene transfer to the nervous system. Prog. Neurobiol. 55:1998;399-432.
31. Young, W. G, E. A. Nimchinsky, P. R. Hof, J. H. Morrison, and, F. E. Bloom, 1997, NeuroZoom Software User Guide and Reference Books, San Diego, YBM Software Associates, 1038, pp. CD-ROM, Internet, http://neurozoom.scripps.edu .
32. Yu S. F., von Ruden T., Kantoff P. W., Garber C., Seiberg M., Ruther U., Anderson W. F., Wager E. Z., Gilboa E. Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. Proc. Natl. Acad. Sci. USA. 83:1986;3194-3198.
33. Zufferey R., Nagy D., Mandel R. J., Naldini L., Trono D. Multiply attenuated lentiviral vector archieves efficient gene delivery in vivo. Nature Biotechnol. 15:1997;871-875.
34. Zufferey R., Dull T., Mandel R. J., Bukovsky A., Quiroz D., Naldini L., Trono D. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol. 72:1998;9873-9880.
35. Zufferey R., Donello J. E., Trono D., Hope T. J. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J Virol. 73:1999;2886-2892.